Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leucine in Midlife Depression
NCT06580145Phase 2Recruiting
- Sponsor
- Emory University
- Start
- Feb 2025
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of l-leucine in major depressive disorder (MDD), sponsored by Emory University. Started Feb 2025; status: recruiting.
02
Drugs
l-leucine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06580145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06580145.